Process development of key intermediates is always conducted in a patent non-infringing manner. Because ScinoPharm's customers
are European and Northern American-based, it is essential that we fully adhere to IP issues.
After conducting a preliminary patent search and developing a process route, we supply
the detailed experimental data to our patent department in ScinoPharm Taiwan so they can conduct
a full IP search to ensure that there is no patent infringement.